Dr. Ava Khosraviani, MD

Dr. Khosraviani practices at Boulevard Surgicenter, Inc. in Encino, California.

Dr. Khosraviani's NPI, 1578717401, was assigned on November 5, 2008. Dr. Khosraviani graduated from Drexel University College Of Medicine in 2006. Dr. Khosraviani's Massachusetts license number on file is 248462.

Dr. Khosraviani's primary practice is Boulevard Surgicenter, Inc., at 16030 W Ventura Blvd, Encino, CA 91436 in Los Angeles County. The practice phone is (818) 990-4545.

Dr. Khosraviani's primary practice is Boulevard Surgicenter, Inc. in Encino, California. The medical group on file is Skinwell Dermatology. Dmand AI also links Dr. Khosraviani to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khosraviani practices. Vendor and product names are available with a free account.

Dermatology is Dr. Khosraviani's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Khosraviani is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Khosraviani's licenses on file in 4 states: Massachusetts, California, New York and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, itchy rashes, joint cyst, minor head injury and minor injury on trunk among the conditions Dr. Khosraviani treats.

CMS data shows 1,514 Medicare services from Dr. Khosraviani across 14 procedure codes in 2024, for 314 Medicare patients. Medicare paid $77,988 for them. Every service was in an office.

CMS counts 314 Medicare patients who saw Dr. Khosraviani in 2024. The largest group is 65 to 74, with 170 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 14% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Khosraviani's median patient age at 56, with 68% women.

In 2024, Dr. Khosraviani wrote 362 Medicare Part D claims for 176 patients. 89% of them were for generic drugs. CMS names the drug for 270 of them, across 10 drugs with 11 or more claims each, at $10,838 in total drug cost. In 2023, CMS named 418 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Khosraviani for performance year 2024, reported individually. Dr. Khosraviani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khosraviani as offering telehealth. CMS counts 489 procedures of removal of skin lesions by Dr. Khosraviani, more than 86% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 944 general payments to Dr. Khosraviani from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Galderma Laboratories, L.P. paid the most, $1,977.

Dr. Khosraviani graduated from Drexel University College Of Medicine in 2006.

Dr. Khosraviani is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.